Istodax

Country: European Union

Language: Maltese

Source: EMA (European Medicines Agency)

Active ingredient:

romidepsin

Available from:

Celgene Europe Ltd.

ATC code:

L01XX39

INN (International Name):

romidepsin

Therapeutic group:

Aġenti antineoplastiċi

Therapeutic area:

Limfoma, Mhux Hodgkin

Therapeutic indications:

it-trattament ta ' T-cell lymphoma (PTCL),.

Authorization status:

Miċħuda

Documents in other languages

Public Assessment Report Public Assessment Report Bulgarian 16-11-2012
Public Assessment Report Public Assessment Report Spanish 16-11-2012
Public Assessment Report Public Assessment Report Czech 16-11-2012
Public Assessment Report Public Assessment Report Danish 16-11-2012
Public Assessment Report Public Assessment Report German 16-11-2012
Public Assessment Report Public Assessment Report Estonian 16-11-2012
Public Assessment Report Public Assessment Report Greek 16-11-2012
Public Assessment Report Public Assessment Report English 16-11-2012
Public Assessment Report Public Assessment Report French 16-11-2012
Public Assessment Report Public Assessment Report Italian 16-11-2012
Public Assessment Report Public Assessment Report Latvian 16-11-2012
Public Assessment Report Public Assessment Report Lithuanian 16-11-2012
Public Assessment Report Public Assessment Report Hungarian 16-11-2012
Public Assessment Report Public Assessment Report Dutch 16-11-2012
Public Assessment Report Public Assessment Report Polish 16-11-2012
Public Assessment Report Public Assessment Report Portuguese 16-11-2012
Public Assessment Report Public Assessment Report Romanian 16-11-2012
Public Assessment Report Public Assessment Report Slovak 16-11-2012
Public Assessment Report Public Assessment Report Slovenian 16-11-2012
Public Assessment Report Public Assessment Report Finnish 16-11-2012
Public Assessment Report Public Assessment Report Swedish 16-11-2012

Search alerts related to this product

View documents history